Prognostics
Age and race should not be used as factors in prostate cancer treatment decision-making
Published in Clinical Oncology Week, November 21st, 2005
Scientists from the United States conducted a study "to provide a single-institution analysis of the impact of age and race on biochemical control after radiotherapy (RT) administered in different prostate cancer scenarios. Age and race are among the most controversial prognostic factors in determining outcome after RT."
"Proper understanding of these prognostic factors can assist in both treatment decision-making and the general understanding of the natural history of prostate cancer. The records of 527 consecutive nonmetastatic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- Cancer Therapy
Progressive muscle relaxation training reduced chemotherapy side effects - Diagnostics
Digital rectal examination cited as barrier to prostate cancer screening - Palliative Care
Methotrimeprazine used in management of nausea and vomiting in advanced cancer - Prognostics
Circulating plasma cells predicted survival in patients with newly diagnosed multiple myeloma - Acute Myeloid Leukemia
Phase II study to evaluate Xanafide in combination with ara-C for secondary AML - Apoptosis
Accumulation of p53 sensitizes human cells to tumor necrosis factor alpha-induced apoptosis - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
